Evidence map›Paper›PMID 32382958›Full record

ArticleUpdates in surgery2020

Long-term results of botulinum toxin type A in complex abdominal wall repair and review of the literature.

Vanesa Catalán-Garza, María Jesús Peña-Soria, Patricia Sáez-Carlin, Juan Jesús Cabeza-Gómez, Andrés García-Fernández, Antonio José Torres-García

Abstract read
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Complex Abdominal Wall Hernias: Structured Use of Adjuvant Therapies.Journal of abdominal wall surgery : JAWS · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vanesa Catalán-GarzaDepartment of General Surgery, Hospital Clínico Universitario San Carlos, Madrid, Spain. vanesacatt@gmail.com.ORCID http://orcid.org/0000-0001-9413-5106
María Jesús Peña-SoriaDepartment of General Surgery, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Patricia Sáez-CarlinDepartment of General Surgery, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Juan Jesús Cabeza-GómezDepartment of General Surgery, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Andrés García-FernándezDepartment of General Surgery, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Antonio José Torres-GarcíaDepartment of General Surgery, Hospital Clínico Universitario San Carlos, Madrid, Spain.
Hospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Administration of botulinum toxin (BTX) is being used in cases of complex ventral hernia for the reconstruction of the linea alba and closure of the abdominal wall. However, there are no published results regarding the long-term effects of BTX and its implication in hernia recurrence. Our purpose is to evaluate the outcomes in hernia recurrence of the administration of BTX in complex ventral hernia repair. 36 patients underwent elective surgery for complex ventral hernia and were evaluated retrospectively. The study included patients with a transverse hernia defect ≥ 100 mm and loss of domain hernias, receiving BTX injections 6 weeks prior to elective surgery. Global results and long-term recurrence were analysed. There were no complications related to BTX administration. The mean transverse hernia defect was 139.44 ± 50.98 mm, the mean abdominal cavity volume (ACV) was 10.19 ± 3.33 dm

Indexed as

Abdominal CavityAbdominal WallAgedBotulinum Toxins, Type AElective Surgical ProceduresFeasibility StudiesFemaleFollow-Up StudiesHernia, VentralHerniorrhaphyHumansIncisional HerniaMaleMiddle AgedRecurrenceRetrospective StudiesBotulinum Toxins, Type ABotulinum toxinHernia recurrenceLong-termVentral hernia

Identifiers

PMID32382958
OpenAlexW3021807165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.